SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-20-087467
Filing Date
2020-07-28
Accepted
2020-07-28 18:01:13
Documents
1
Period of Report
2020-07-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 tm2025948d1_form4.html 4  
1 FORM 4 tm2025948d1_form4.xml 4 3055
  Complete submission text file 0001104659-20-087467.txt   4686
Mailing Address 4260 U.S. ROUTE 1 MONMOUTH JUNCTION NJ 08852
Business Address 4260 U.S. ROUTE 1 MONMOUTH JUNCTION NJ 08852 6096193990
Outlook Therapeutics, Inc. (Issuer) CIK: 0001649989 (see all company filings)

IRS No.: 383982704 | State of Incorp.: DE | Fiscal Year End: 0930
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 1517 CHAMPLAIN CREST WAY CARY NC 27513
Business Address 1517 CHAMPLAIN CREST WAY CARY NC 27513 781-308-0823
Syntone Ventures LLC (Reporting) CIK: 0001814394 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-37759 | Film No.: 201055019